EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine

Patricia Teixeira Santana iD, Isadora Schmukler de Lima, Karen Cristina da Silva E Souza, Pedro Henrique Sales Barbosa iD, Heitor Siffert Pereira de Souza iD

International Journal of Molecular Sciences · 10.10.2024 · 25 (20) · 10874

DOI: 10.3390/ijms252010874 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.10.2024. Verfasst von Patricia Teixeira Santana und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant signaling through damage-associated molecular patterns (DAMPs) has been linked to several health disorders, attracting considerable research interest over the last decade. Adenosine triphosphate (ATP), a key extracellular DAMP, activates the purinergic receptor P2X7, which acts as a danger sensor in immune cells and is implicated in distinct biological functions, including cell death, production of pro-inflammatory cytokines, and defense against microorganisms. In addition to driving inflammation mediated by immune and non-immune cells, the persistent release of endogenous DAMPs, including ATP, has been shown to result in epigenetic modifications. In intestinal diseases such as inflammatory bowel disease (IBD) and colorectal cancer (CRC), consequent amplification of the inflammatory response and the resulting epigenetic reprogramming may impact the development of pathological changes associated with specific disease phenotypes. P2X7 is overexpressed in the gut mucosa of patients with IBD, whereas the P2X7 blockade prevents the development of chemically induced experimental colitis. Recent data suggest a role for P2X7 in determining gut microbiota composition. Regulatory mechanisms downstream of the P2X7 receptor, combined with signals from dysbiotic microbiota, trigger intracellular signaling pathways and inflammasomes, intensify inflammation, and foster colitis-associated CRC development. Preliminary studies targeting the ATP−P2X7 pathway have shown favorable therapeutic effects in human IBD and experimental colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Purinergic P2X7HumansAnimalsInflammationInflammatory Bowel DiseasesAdenosine TriphosphateGastrointestinal MicrobiomeSignal TransductionIntestinal MucosaColorectal NeoplasmsIntestines

Stichwörter der Autor:innen

ATPP2X7colorectal cancerdamage-associated molecular patternsinflammatory bowel disease

Substanzen

Receptors, Purinergic P2X7Adenosine Triphosphate

Autor:innen und Institutionen

  • Department of Clinical Medicine, Federal University of Rio de Janeiro, Rio de Janeiro 21941-913, Brazil.
  • D'Or Institute for Research and Education (IDOR), Rua Diniz Cordeiro 30, Botafogo, Rio de Janeiro 22281-100, Brazil.

ORCID-Profile: Patricia Teixeira Santana, Pedro Henrique Sales Barbosa, Heitor Siffert Pereira de Souza

Förderung

  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • National Council for Scientific and Technological Development
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • D'Or Institute for Research and Education
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil (CAPES)
  • Instituto D’Or de Pesquisa e Ensino (IDOR)

Zitieren

APA

Santana, P. T., de Lima, I. S., Silva E Souza, K. C. D., Barbosa, P. H. S., & de Souza, H. S. P. (2024). Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine. International Journal of Molecular Sciences, 25(20), 10874. https://doi.org/10.3390/ijms252010874

Vancouver

Santana PT, de Lima IS, Silva E Souza KCD, Barbosa PHS, de Souza HSP. Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine. International Journal of Molecular Sciences. 2024;25(20):10874. doi:10.3390/ijms252010874

BibTeX
@article{Santana2024,
  author = {Santana, Patricia Teixeira and de Lima, Isadora Schmukler and Silva E Souza, Karen Cristina da and Barbosa, Pedro Henrique Sales and de Souza, Heitor Siffert Pereira},
  title = {Persistent Activation of the P2X7 Receptor Underlies Chronic Inflammation and Carcinogenic Changes in the Intestine},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {10874},
  doi = {10.3390/ijms252010874}
}
Kostenlos starten →